Coronavirus: COVID-19
The Atlantic’s coverage of the coronavirus that causes COVID-19
The Atlantic’s coverage of the coronavirus that causes COVID-19
Only 35 percent of Arkansas is fully vaccinated, and with case rates rising, living there can feel like moving through a distorted reality.
There’s no good way of measuring whether your vaccine worked—yet.
COVID-19 vaccination rates have fallen off a cliff. Will it take a deadly summer surge to change things?
For America as a whole, the pandemic might be fading. For some communities, this year will be worse than last.
Lumping all breakthroughs together, regardless of symptoms, miscasts what our COVID-19 vaccines can do.
Weighing the balance of risks is a shade more challenging when it affects the youngest among us.
The variants are spreading faster, but they don’t necessarily have incentive to kill more often.
A vaccinated American’s guide to traveling this summer
Research can tell us only so much. The rest is a waiting game.
Our pandemic podcast is ending, though the pandemic hasn’t ended around the world.
We understand how this will end. But who bears the risk that remains?
The traumas of the past year have left some people wrestling with an awful question: Am I still a good person?
Our tests will need frequent touch-ups to make sure that no mutations get past them.
Things are starting to look up, at least in the U.S., but we’re looking ahead at potential future worries.
Lots of your questions about the future after COVID-19 get answered, and one listener gives us a little history lesson.
Post-vaccination infections reveal how effective vaccines are—and which variants are sneaking past our defenses.
It’s time for more weapons in the shots-versus-virus arms race.
The Atlantic staff writer Ed Yong talks with James Hamblin and Maeve Higgins about the ways, large and small, in which we’ve all suffered.
The pandemic’s mental wounds are still wide open.
What difference could it make worldwide if the U.S. waived patents for vaccines?